deucravacitinib
bms
[' psa', '#2132', 'ease,(-please),(-disease),(-incrrease),(-decrease)', 'deucra']
fleischmann et al. safety of tyk2i deucravacitinib in psa/pso in terms of labs. really no effect on lab values other than increase in trigs. guess this is why they don't have lab monitoring on label? #acr22 abstr#2132 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC